|Title:||Malaria treatment policy and drug resistance monitoring in countries of Soouth-East Asia Region : report of a workshop, Bali, Indonesia, 15-17 September 2010|
|Authors:||World Health Organization, Regional Office for South-East Asia|
|Publisher:||WHO Regional Office for South-East Asia|
|Place of publication:||New Delhi|
|Abstract:||Description: The rapid spread of resistance to several antimalarial drugs has led to the revision of the national treatment guidelines and intensification of monitoring of therapeutic efficacies of currently used antimalarial drugs. The recent emergence of artemisinin resistance in the Greater Mekong Sub-region necessitated the strengthening of drug resistance monitoring and networking for effective information exchange that is essential for tracking the spread of the resistance. Several new tools have been developed and are deployed for drug resistance monitoring. A workshop on Malaria treatment policy and drug resistance monitoring in countries of the South-East Asia Region was organized in Bali, Indonesia from 15-17 September 2010. Seven Member States (Bangladesh, Bhutan, India, Indonesia, Nepal, Sri Lanka and Timor-Leste) participated. The primary aims of the workshop were to update and revitalize the national therapeutic efficacy studies and drug resistance monitoring for strengthening treatment of malaria in Member States. The current national treatment guidelines were reviewed. Lessons learnt from the Mekong Malaria Programme on early signs of artemisinin resistance, maintaining quality drug resistance monitoring and networking were shared. Several technical and operational recommendations were made to Member States and WHO.|
|Gov't Doc #:||SEA-MAL-267|
|Appears in Collections:||Meeting Reports|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.